New Investment Supports Neuroinflammation Research

Screen Shot 2017-09-01 at 12.17.20 PMAugust 2017 | A NEW INVESTMENT FROM Slater Technology Fund supports Ryan Institute partner MindImmune Therapeutics in pioneering research on the role of neuroinflammation in neurodegenerative disease.

Read more about the MindImmune team’s research and partnership with URI here on ConvergenceRI.

Photo Richard Asinof/ConvergenceRI